SCHEMBL24925447

SCHEMBL24925447

CC(C)(C)c1cccc(/C=C/C(=O)NO)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 6/20 0.59
HDAC3 O15379 5/20 0.59
HDAC2 Q92769 5/20 0.59
HDAC8 Q9BY41 5/20 0.59
HDAC6 Q9UBN7 4/20 0.59
HDAC4 P56524 4/20 0.59
TRPV1 Q8NER1 3/20 0.57
HDAC10 Q969S8 3/20 0.56
HDAC11 Q96DB2 3/20 0.56
HDAC5 Q9UQL6 3/20 0.56
HDAC7 Q8WUI4 2/20 0.56
HDAC9 Q9UKV0 2/20 0.56
MEN1 O00255 1/20 0.52
LMNA P02545 1/20 0.52
HSP90AA1 P07900 1/20 0.52
MAPT P10636 1/20 0.52
PKM P14618 1/20 0.52
KMT2A Q03164 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
ADAM17 P78536 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8242895 0.88 TRPV1 (0.57) HDAC1HDAC3TRPV1MEN1LMNA
SCHEMBL4001262 0.82 CYP26B1 (0.60) HDAC1HDAC3HDAC2HDAC8HDAC6
SCHEMBL4001259 0.82 CYP26B1 (0.60) HDAC1HDAC3HDAC2HDAC8HDAC6
SCHEMBL10019336 0.82 CYP1A2 (0.70) HDAC1HDAC3HDAC2HDAC8HDAC6
SCHEMBL5436010 0.81 TRPV1 (0.52) TRPV1MEN1LMNAHSP90AA1MAPT
SCHEMBL5436012 0.81 TRPV1 (0.52) TRPV1MEN1LMNAHSP90AA1MAPT
SCHEMBL12993167 0.81 TTR (0.54) TRPV1MEN1LMNAHSP90AA1MAPT
SCHEMBL8302981 0.79 HDAC1 (0.65) HDAC1HDAC3HDAC2HDAC8HDAC6
SCHEMBL13762597 0.77 HDAC1 (0.77) HDAC1HDAC3HDAC2HDAC8HDAC6
SCHEMBL12426058 0.77 HSD17B3 (0.71) HDAC1HDAC3HDAC2HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230022696-A1 SMALL MOLECULE INHIBITORS OF AUTOPHAGY AND HISTONE DEACTYLASES AND USES THEREOF ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230022696-A1 SMALL MOLECULE INHIBITORS OF AUTOPHAGY AND HISTONE DEACTYLASES AND USES THEREOF HDAC5, HDAC4, HDAC7 HDAC1 5/4885HDAC3 4/4885HDAC2 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.